Skip to content
WeighLab
Menu
Ranked #334 · Grade C

Mint Med review

Mint Med (mintmed.com) is a compounded GLP-1 telehealth service charging one flat '$159/mo, all doses' price with no separate semaglutide/tirzepatide tiers, serving 35 named states (notably excluding several large ones).

Visit Mint Med Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
36 states
Brand-name
Compounded only

Pricing verified August 2026

The Index scorecard

Mint Med scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency54/100
Nationwide Access66/100
Formulation Options40/100
Clinical Oversight74/100
Contract Flexibility61/100

Where the value is

  • Single, simple flat price ($159/mo) applies to any dose of either drug — no dose-escalation surcharge structure to parse
  • No membership fee ('NO memberships!') and cancellation requires only 48 business hours notice
  • Explicit immediate-refund commitment if a clinical reviewer finds the applicant ineligible
  • States served are listed explicitly by name rather than left vague

The tradeoffs

  • Payment is collected upfront, before a clinician has reviewed and approved the prescription — patients front the money before knowing they'll be approved
  • Only 35 states are served by name — notably absent are several populous states not on the published list, so most shoppers should check it before assuming eligibility
  • No named prescriber, medical director, or specific compounding pharmacy disclosed — only generic 'partner U.S. state licensed pharmacies' language
  • One flat price for both semaglutide and tirzepatide is unusual in this market (tirzepatide typically costs more); worth confirming this holds at every dose tier rather than assuming it from the headline alone
  • FDA issued Glow Medispa, LLC dba Mint Med a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Cost-first shoppers who want the simplicity of one flat price across both semaglutide and tirzepatide, in the 35 states it explicitly serves. Mint Med (mintmed.com) is a compounded GLP-1 telehealth service charging one flat '$159/mo, all doses' price with no separate semaglutide/tirzepatide tiers, serving 35 named states (notably excluding several large ones).

Ranked #334 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Mint Med.

The 24 programs nearest this one

Pricing, states and verification reflect Mint Med's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Mint Med's site. Not medical advice; see our disclosure.

← Back to the value leaderboard